| Brian A. Markison |
Brian A. Markison is a businessperson who has been at the head of 10 different companies and presently holds the position of Non-Executive Chairman at Lantheus Holdings, Inc., Non-Executive Chairman for Lantheus Medical Imaging, Inc. (a subsidiary of Lantheus Holdings, Inc.) and Chairman & Chief Executive Officer for Osmotica Pharmaceuticals Plc, Chairman & Chief Executive Officer for Osmotica Holdings Corp. Ltd. and Chief Executive Officer of Osmotica Pharmaceutical Corp. (both are subsidiaries of Osmotica Pharmaceuticals Plc). Mr. Markison is also on the board of 8 other companies.
In the past he was Chairman at Rosetta Genomics Ltd., Executive Chairman of Vertical and Executive Chairman for Vertical Pharmaceuticals LLC (a subsidiary of Vertical), President-Oncology & Virology at Bristol Myers Squibb Co., Chairman, President & Chief Executive Officer at KP Pharmaceuticals LLC, President, Chief Executive Officer & Director at Fougera Pharmaceuticals, Inc. and President at Oncology Therapeutics Network Corp.
Mr. Markison received an undergraduate degree from Iona College. |
| Andrew J. Einhorn |
Founder of Oceana Therapeutics, Inc., ESP Pharma, Inc. and Esprit Pharma, Inc., Andrew J. Einhorn is an entrepreneur who presently occupies the position of Chief Financial Officer for Osmotica Pharmaceuticals Plc.
He previously was Chief Financial Officer & Senior Vice President of ESP Pharma, Inc., Chief Financial Officer & Executive Vice President for Esprit Pharma, Inc., Chief Financial Officer of MYOS RENS Technology, Inc., Chief Financial Officer of Edge Therapeutics, Inc. and Chief Financial Officer & Executive VP for Oceana Therapeutics, Inc.
Andrew J. Einhorn received an undergraduate degree from Middlebury College, a graduate degree from Northwestern University and an undergraduate degree from American University. |
| James Schaub |
James Schaub is Chief Operating Officer & Executive Vice President for Osmotica Pharmaceuticals Plc.
In the past he occupied the position of Chief Operating Officer at Trigen Laboratories LLC and Vice President-M&A Division at Fougera Pharmaceuticals, Inc.
James Schaub received an undergraduate degree from Middlebury College and an MBA from Rutgers Business School. |
| Gregory L. Cowan |
Gregory L. Cowan is on the board of Emtec, Inc., VWR Foundation and Osmotica Pharmaceuticals Plc and Vice President of VWR Funding, Inc.
Mr. Cowan previously occupied the position of Chief Financial Officer & Executive Vice President for Avantor, Inc. Chief Financial Officer & Executive Vice President for VWR Corp. and Chief Financial Officer & Senior Vice President at VWR International LLC (both are subsidiaries of Avantor, Inc.), Chief Accounting Officer & Senior Vice President of CDI Corp., Senior Manager at Pricewaterhousecoopers LLC and Vice President-Internal Audit at Crown Cork & Seal Co., Inc.
Gregory L. Cowan received an undergraduate degree from Rutgers State University of New Jersey. |
| Fred G. Weiss |
Fred G. Weiss is on the board of The Michael J. Fox Foundation for Parkinson's Research and Osmotica Pharmaceuticals Plc and Managing Director at Fgw Consultancy LLC.
In his past career he occupied the position of Managing Director at FGW Associates, Inc. and VP-Planning, Investment & Development at Warner-Lambert Co.
Fred G. Weiss received an undergraduate degree from the University of Pennsylvania and an MBA from The University of Chicago. |
| Michael J. DeBiasi |
Currently, Michael J. DeBiasi holds the position of Chief Executive Officer for Arcadia Consumer Healthcare, Inc. He is also on the board of Osmotica Pharmaceuticals Plc.
Mr. DeBiasi received an MBA from Kellogg School of Management and an undergraduate degree from the University of Notre Dame. |
